2
results found
Background Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed in oncology settings, yet their direct effects on endometrial cancer cell fate and survival signaling remain unclear....
Fluoxetine
Endometrial cancer
ERK1/2 signaling
Phosphorylated ERK1/2 (pERK1/2)
Annexin V/propidium iodide
TUNEL assay
In certain populations, founder pathogenic variants are a common cause of Lynch syndrome. Here, we report the identification of a novel founder variant, NM_000179.3 (MSH6):c.2061T > G (p.Cys687Trp). O...
Founder variant
Lynch syndrome
variant of uncertain significance
immunohistochemistry
haplotype
endometrial cancer
SinoXiv